These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 2803984
1. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size. Federici AB, Bader R, Pagani S, Colibretti ML, De Marco L, Mannucci PM. Br J Haematol; 1989 Sep; 73(1):93-9. PubMed ID: 2803984 [Abstract] [Full Text] [Related]
2. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. De Marco L, Mazzucato M, De Roia D, Casonato A, Federici AB, Girolami A, Ruggeri ZM. J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830 [Abstract] [Full Text] [Related]
3. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J. J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224 [Abstract] [Full Text] [Related]
4. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions. Rivera J, Escolar G, Casamiquela R, Bravo MI, Jorquera JI, Castillo R, Ordinas A, Vicente V. Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386 [Abstract] [Full Text] [Related]
5. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Moore JC, Murphy WG, Kelton JG. Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725 [Abstract] [Full Text] [Related]
6. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Weiss HJ, Sussman II. Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353 [Abstract] [Full Text] [Related]
7. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib. George JN, Torres MM. Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766 [Abstract] [Full Text] [Related]
8. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. Casonato A, De Marco L, Mazzucato M, De Angelis V, De Roia D, Fabris F, Ruggeri ZM, Girolami A. Blood; 1989 Nov 01; 74(6):2028-33. PubMed ID: 2804346 [Abstract] [Full Text] [Related]
9. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Berndt MC, Du XP, Booth WJ. Biochemistry; 1988 Jan 26; 27(2):633-40. PubMed ID: 2450575 [Abstract] [Full Text] [Related]
10. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM. Proc Natl Acad Sci U S A; 1985 Nov 26; 82(21):7424-8. PubMed ID: 2932740 [Abstract] [Full Text] [Related]
11. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib. Rabinowitz I, Randi AM, Shindler KS, Tuley EA, Rustagi PK, Sadler JE. J Biol Chem; 1993 Sep 25; 268(27):20497-501. PubMed ID: 8376405 [Abstract] [Full Text] [Related]
12. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. De Marco L, Mazzuccato M, Grazia Del Ben M, Budde U, Federici AB, Girolami A, Ruggeri ZM. J Clin Invest; 1987 Aug 25; 80(2):475-82. PubMed ID: 3038958 [Abstract] [Full Text] [Related]
13. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC. Biochemistry; 1989 Oct 17; 28(21):8317-26. PubMed ID: 2557900 [Abstract] [Full Text] [Related]
14. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers. Gjønnaess E, Solum NO, Brosstad F. Blood Coagul Fibrinolysis; 1992 Aug 17; 3(4):395-405. PubMed ID: 1420815 [Abstract] [Full Text] [Related]
15. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets. Cooney KA, Lyons SE, Ginsburg D. Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):2869-72. PubMed ID: 1557393 [Abstract] [Full Text] [Related]
16. Purification and characterization of human platelet von Willebrand factor. Williams SB, McKeown LP, Krutzsch H, Hansmann K, Gralnick HR. Br J Haematol; 1994 Nov 01; 88(3):582-91. PubMed ID: 7819071 [Abstract] [Full Text] [Related]
19. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. Grainick HR, Williams SB, Coller BS. J Clin Invest; 1985 Jan 01; 75(1):19-25. PubMed ID: 2981249 [Abstract] [Full Text] [Related]